- Filed
- Mar 27, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2025 · Dec 31, 2025 | 905.08M sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2024 | 891.76M sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2023 | 891.76M sh |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$79.61M |
| Operating Cash Flow restated | FY 2025 · Dec 31, 2024 | −$54.03M |
| Operating Cash Flow restated | FY 2025 · Dec 31, 2023 | −$55.97M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $665.82M |
| Stockholders Equity restated | FY 2025 · Dec 31, 2024 | $1.02B |
| Stockholders Equity restated | FY 2025 · Dec 31, 2023 | $473.78M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $111.59M |
| Current Liabilities restated | FY 2025 · Dec 31, 2024 | $50.34M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $580.69M |
| Total Liabilities restated | FY 2025 · Dec 31, 2024 | $91.33M |
| Current Assets | FY 2025 · Dec 31, 2025 | $8.92M |
| Current Assets restated | FY 2025 · Dec 31, 2024 | $153.12M |
| Total Assets | FY 2025 · Dec 31, 2025 | $1.25B |
| Total Assets restated | FY 2025 · Dec 31, 2024 | $1.11B |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$0.17 |
| Eps Diluted restated | FY 2025 · Dec 31, 2024 | $0.49 |
| Eps Diluted restated | FY 2025 · Dec 31, 2023 | $0.04 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$0.17 |
| Eps Basic restated | FY 2025 · Dec 31, 2024 | $0.49 |
| Eps Basic restated | FY 2025 · Dec 31, 2023 | $0.04 |
| Net Income | FY 2025 · Dec 31, 2025 | −$153.17M |
| Net Income | FY 2025 · Mar 31, 2025 | −$100.62M |
| Net Income restated | FY 2025 · Dec 31, 2024 | $428.94M |
| Net Income restated | FY 2025 · Dec 31, 2023 | $39.61M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$227.99M |
| Operating Income restated | FY 2025 · Dec 31, 2024 | $484.1M |
| Operating Income restated | FY 2025 · Dec 31, 2023 | $6.24M |
| Cost Of Revenue | FY 2025 · Dec 31, 2025 | $92M |
| Cost Of Revenue restated | FY 2025 · Dec 31, 2024 | $39.51M |
| Cost Of Revenue restated | FY 2025 · Dec 31, 2023 | $43.61M |
| Capex restated | FY 2025 · Dec 31, 2024 | $6.61M |